1mg, best e pharmacy in India


Rs.101110for 1 bottle(s) (50 ML infusion each)
Unfortunately, we don't have any more items in stock
Report Error

Composition FOR ERBITUX

Cetuximab(500 mg)

food interaction for ERBITUX

alcohol interaction for ERBITUX

pregnancy interaction for ERBITUX

lactation interaction for ERBITUX

It can be taken with or without food, but it is better to take Erbitux 500mg infusion at a fixed time.
Interaction with alcohol is unknown. Please consult your doctor.
Erbitux 500mg infusion may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Erbitux 500mg infusion is probably unsafe to use during breastfeeding. Please consult your doctor.


Cetuximab(500 mg)


Erbitux 500mg infusion is used in the treatment of head and neck cancer and cancer of colon and rectum

How it works

Erbitux 500mg infusion is a monoclonal antibody that specifically binds to receptors on cancer cells. Thus Erbitux 500mg infusion flags the cancer cells for destruction by the body's immune system.

Common side effects

Nausea, Liver enzyme increased, Conjunctivitis, Dehydration, Diarrhoea, Intestinal injury, Headache, Decreased calcium level in blood, Decreased magnesium level in blood, Weakness, Infusion site reaction, Loss of appetite, Nasal mucous injury, Skin reaction, Vomiting


No substitutes found

Expert advice FOR ERBITUX

  • Administration of anti-allergy medication including steroids is mandatory at least one hour before cetuximab infusion.
  • Caution is to be observed while driving or using machinery after taking Cetuximab.
  • Cetuximab may also adversely affect skin and eyes with symptoms like blurred vision, eye pain and dry eye.
  • Frequent monitoring for infections and levels of white blood cells is required, if cetuximab is given with certain other anti-cancer drugs (platinum compounds like cisplatin, carboplatin, oxaliplatin).
  • There is increased risk of occurrence of heart problems if cetuximab is given with certain other anti-cancer drugs (fluoropyrimidines like capecitabine, fluorouracil).
  • Caution is to be observed in case of administering cetuximab to elderly patient with heart problems.

Frequently asked questions FOR ERBITUX


Q. Is cetuximab a chemotherapy drug?
Cetuximab is a cytotoxic drug that is used in the chemotherapy of cancers of colon and rectum, and head-neck cancers

Q. Is cetuximab cytotoxic agent or vesicant or radiosensitizer?
It is not a radiosensitizer, but usually used in combination with radiotherapy to treat the cancers. It is not a vesicant (irritant)

Q. Is cetuximab US FDA approved?
Yes, cetuximab is approved by US FDA in 2009 to treat certain type of cancer of colon, rectum and head-neck cancer

Q. How is cetuximab administered?
Cetuximab is generally administered by intravenous (IV infusion) route, with or without radiotherapy

Q. Does cetuximab cause hair loss?
Yes. Cetuximab is a chemotherapy agent, which may cause hair loss. Please consult your doctor if you experience such side effect

Q. Why does cetuximab cause a rash?
Cetuximab may cause rashes

Q. How long does the rash last?
The duration of skin rash depends upon its type and severity. Please consult your doctor for advice.


Content on this page was last updated on 12 January, 2017, by Dr. Varun Gupta (MD Pharmacology)